Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Corvus Pharmaceuticals, Inc. (CRVS)

10.03 -0.20 (-1.96%)
At close: October 30 at 4:00:01 PM EDT
10.03 0.00 (0.00%)
After hours: October 30 at 4:00:16 PM EDT
Trade CRVS on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
56,963
42,971
27,548
23,407
32,565
Operating Income
-56,963
-42,971
-27,548
-23,407
-32,565
Net Non Operating Interest Income Expense
5,172
2,505
1,824
1,584
654
Other Income Expense
-2,338
25,183
-36,569
-5,206
-9,396
Pretax Income
-54,129
-15,283
-62,293
-27,029
-41,307
Net Income Common Stockholders
-54,129
-15,283
-62,293
-27,029
-41,307
Diluted NI Available to Com Stockholders
-26,988
-15,283
-62,293
-27,029
-41,307
Basic EPS
-0.64
-0.19
-1.02
-0.56
-0.89
Diluted EPS
-0.64
-0.53
-1.02
-0.56
-0.89
Basic Average Shares
87,076.29
78,964.84
60,985.17
48,025.27
46,553.51
Diluted Average Shares
87,076.29
79,742.69
60,985.17
48,025.27
46,553.51
Total Operating Income as Reported
-56,963
-42,971
-27,548
-23,407
-32,565
Total Expenses
56,963
42,971
27,548
23,407
32,565
Net Income from Continuing & Discontinued Operation
-54,129
-15,283
-62,293
-27,029
-41,307
Normalized Income
-54,129
-42,424
-28,921
-27,029
-41,329
Interest Income
5,172
2,505
1,824
1,584
654
Net Interest Income
5,172
2,505
1,824
1,584
654
EBIT
-56,963
-42,971
-27,548
-23,407
-32,565
EBITDA
-56,846
-42,866
-27,463
-23,256
-32,198
Reconciled Depreciation
117
105
85
151
367
Net Income from Continuing Operation Net Minority Interest
-54,129
-15,283
-62,293
-27,029
-41,307
Total Unusual Items Excluding Goodwill
0
27,141
-33,372
0
22
Total Unusual Items
0
27,141
-33,372
0
22
Normalized EBITDA
-56,846
-70,007
5,909
-23,256
-32,220
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 3/23/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: